Sung Ho Park

Dr. Sung Ho Park

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2024 in Life
Verified
Journal Article
Open access
HCHYUNJEONG CHO
HYUNJEONG CHO
JLJong-Min Lee
Jong-Min Lee
SPSung Ho Park
Sung Ho Park
JPJun-Bum Park
Jun-Bum Park
NJNa Young Jung
Na Young Jung
This retrospective study aimed to evaluate the impact of radiation dose on the outcomes of stereotactic radiosurgery (SRS) for benign meningiomas and determine an optimal dosing strategy for balancing tumor control and treatment-related toxicity. Clinical data of 147 patients with 164 lesions treated between 2014 and 2022 were reviewed. Primary outcomes included progression-free survival (PFS), local control rate (LCR), and radiation-induced toxicity, with secondary outcomes focusing on LCR and radiation-induced peritumoral edema (PTE) in two dose groups (≥14 Gy and <14 Gy). The results revealed a median follow-up duration of 47 months, with 1-year, 2-year, and 5-year PFS rates of 99.3%, 96.7%, and 93.8%, respectively, and an overall LCR of 95.1%. Radiation-induced toxicity was observed in 24.5% of patients, primarily presenting mild symptoms. Notably, no significant difference in LCR was found between the two dose groups (p = 0.628), while Group 2 (<14 Gy) exhibited significantly lower PTE (p = 0.039). This study concludes that SRS with a radiation dose < 14 Gy demonstrates comparable tumor control with reduced toxicity, advocating consideration of such dosing to achieve a balance between therapeutic efficacy and safety.

1 March 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
SPSung Ho Park
Sung Ho Park
YPYoung-Kwon Park
Young-Kwon Park
JCJinwoo Choi
Jinwoo Choi
MOMinsu Ock
Minsu Ock
DYDongseok Yang
Dongseok Yang
Background/Objectives: Osmotic demyelination syndrome (ODS) causes marked myelin loss with relative axonal preservation. We used diffusion tensor imaging (DTI) to longitudinally assess white matter (WM) changes, hypothesizing that radial diffusivity (RD) would show dynamic recovery alongside clinical improvement. Methods: A 40-year-old woman with ODS and five age-matched female controls underwent DTI at 7 weeks and 6 months post-onset. Metrics were extracted from 27 WM tract categories using atlas-based regions of interest. Lesions were defined by directional dual thresholds (RD_d ≥ 2.0, axial diffusivity [AD] ≤ −2.0, or fractional anisotropy [FA] ≤ −2.0) and confirmed using the Crawford–Howell test with Benjamini–Hochberg FDR correction (q ≤ 0.05). Longitudinal percent change (Δ%) was compared using the Friedman test with Bonferroni-corrected Wilcoxon post hoc tests (α = 0.017). Results: Serum sodium increased from 126 to 138 mmol/L within 24 h, followed by a severe neurological deficit; near-complete recovery by 6 months. At 7 weeks, RD-defined lesions were detected in 10/27 tracts (37.0%)—1/6 brainstem-related and 9/21 non-brainstem—indicating widespread myelin-predominant injury. No AD- or FA-based lesions met criteria, although AD increase in the cingulate gyrus was significant. From 7 weeks to 6 months, the mean Δ% was −0.40 ± 9.38% (AD), −4.73 ± 9.73% (RD), and +7.94 ± 7.53% (FA). Changes differed across metrics (χ2(2) = 24.07, p = 5.92 × 10−6), with greater RD and FA changes than AD. Conclusions: Early RD-predominant abnormalities preceded RD reduction and FA increase during recovery, consistent with restoration of myelin-related microstructure. Larger studies are warranted.

17 April 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
HCHYUNJEONG CHO
HYUNJEONG CHO
JLJong Min Lee
Jong Min Lee
SPSung Ho Park
Sung Ho Park
JPJun Bum Park
Jun Bum Park
NJNa Young Jung
Na Young Jung
This retrospective study aimed to evaluate the impact of radiation dose on the outcomes of stereotactic radiosurgery (SRS) for benign meningiomas and determine an optimal dosing strategy for balancing tumor control and treatment-related toxicity. Clinical data of 147 patients with 164 lesions treated between 2014 and 2022 were reviewed. Primary outcomes included progression-free survival (PFS), local control rate (LCR), and radiation-induced toxicity, with secondary outcomes focusing on LCR and radiation-induced peritumoral edema (PTE) in two dose groups (≥14 Gy and <14 Gy). Results revealed a median follow-up duration of 47 months, with 1-year, 2-year, and 5-year PFS rates of 99.3%, 96.7%, and 93.8% respectively, and an overall LCR of 95.1%. Radiation-induced toxicity was observed in 24.5% of patients, primarily presenting mild symptoms. Notably, no significant difference in LCR was found between the two dose groups (P = 0.628), while Group 2 (<14 Gy) exhibited significantly lower PTE (P = 0.039). The study concludes that SRS with a radiation dose <14 Gy demonstrates comparable tumor control with reduced toxicity, advocating for consideration of such dosing to achieve a balance between therapeutic efficacy and safety.

1 January 2017 in Progress in Medical Physics
Verified
Journal Article
Open access
PDF file
GBGeum-Mun Back
Geum-Mun Back
SPSung Ho Park
Sung Ho Park
TKTae-Hyung Kim
Tae-Hyung Kim
Back GM, et al. Prog Med Phys. 2017 Jun;28(2):45-48. https://doi.org/10.14316/pmp.2017.28.2.45

1 January 2015 in Progress in Medical Physics
Verified
Journal Article
Open access
YKYoung Eun Ko
Young Eun Ko
HJHyoung Uk Je
Hyoung Uk Je
YHYeon Hwang
Yeon Hwang
SPSung Ho Park
Sung Ho Park
In this study, the reduction of dose and risk was evaluated from using automatic mA control in 4D CT scan of patients whose organ movement was considered for gated radiotherapy. The organ doses, CTDI, effective doses from 4D CT with and without using automatic mA control were evaluated using CT-Expo program for each 10 patients of liver and lung cancer, and the risk of exposure induced death and loss of life expectancy were evaluated using PCXMC program. It was founded that there were 26.8%, and 15.5% dose reduction in organ doses and CTDI for liver and lung cancer patients and 16.5% and 19.8% risk reduction in liver and lung cancer patients. The organ doses and effective doses were evaluated for the parameter of each patient used in CT scans, and risks considering age and gender could be evaluated. It was founded that there were 21.2% dose reduction and 18.2% risk reduction in 4D CT scan using AEC for liver and lung cancer patients.